NCT00565851 2025-12-30Carboplatin, Paclitaxel and Gemcitabine Hydrochloride With or Without Bevacizumab After Surgery in Treating Patients With Recurrent Ovarian, Epithelial, Primary Peritoneal, or Fallopian Tube CancerNational Cancer Institute (NCI)Phase 3 Active not recruiting1,052 enrolled 27 charts